Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03784495Completed
Randomised, double-blind trial of melatonin in Sarcopenia (4 arms), sponsored by ASP Pavia. Primary endpoints: Change in Total Fat Mass at 30 days, Change in Total Free Fat Mass at 30 days and 1 more. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03784495.